Concurrent chemoradiotherapy in cervix carcinomas;Les chimioradiotherapies dans les cancers du col uterin

Cancer/Radiotherapie

Volumn 2, Issue 6, 1998, Pages 718-722

  Maingon, P ^a   Coucke, P ^b   Haie Meder C ^c   Barillot, I ^a  

^a CENTRE GEORGES FRANÇOIS LECLERC   (France)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cervix carcinoma; Concurrent chemotherapy; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; HYDROXYUREA; MITOMYCIN C; RADIOSENSITIZING AGENT; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; DRUG INDUCED DISEASE; FEMALE; HUMAN; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; TREATMENT OUTCOME; UTERINE CERVIX TUMOR;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; PROGNOSIS; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0032294684     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(99)80014-6     Document Type: Article

References (40)

1. 1 Aghajanian C, Brown C, O'Flaferty C, Fleischauer A, Curtin J, von Roemeling R et al. Phase I study of tirapazamine and cisplatin in patients with recurrent cervical cancer. Gynecol Oncol 1997 ; 67 : 127-37
2. 2 Barillot I, Horiot JC, Pigneux J, Schraub S, Pourquier H, Daly N et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 1997 ; 38 : 969-78
3. 3 Bush RS. The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys 1986 ; 12 : 2047-50
4. 4 Chauvergne J, Lhommé C, Rohart J, Héron JF, Ayme Y, Goupil A et al. Chimiothérapie néoadjuvante des cancers du col utérin aux stades IIb et IIIb. Résultats éloignés d'un essai randomisé pluricentrique portant sur 151 patients. Bull Cancer 1993 ; 80 : 1069-79
5. 5 Christie DR, Bull CA, Gebski V, Langlands A. Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer. Radiother Oncol 1995 ; 37 : 181-9
6. 6 Disaia PJ, Bundy BN, Curry SL, Schlaerth J, Thigpen JT. Phase III study of the treatment of women with cervical cancer stage IIB, IIIB and IVA (confined to the pelvis and/or in paraaortic nodes) with radiotherapy alone versus radiotherapy plus immunotherapy with intravenous corynebacterium parvum): a GOG study. Gynecol Oncol 1987 ; 26 : 386-94
7. 7 Dische S, Chassagne D, Hope-stone HF, Dawes PJDK, Roberts JT, Yosef H et al. A trial of Ro 03-8799 (pimonidazole) in carcinoma of the uterine cervix: an interim report of the Medical Research Council Working Party on Advanced Carcinoma of the Cervix. Radiother Oncol 1993 ; 26 : 93-103
8. 8 Gerbaulet A, Kunkler IH, Kerr GR, Haie C, Michel G, Prade M et al. Combined radiotherapy and surgery: local control and complications in early carcinoma of the uterine cervix. The Villejuif experience 1975-1984. Radiother Oncol 1992 ; 23 : 66-73
9. 9 Gray AJ, Dische S, Adams GE, Flockart IR, Foster JL. Clinical testing of the radiosensitizer Ro 03-0582. I. Dose tolerance and tumor concentration. Clin Radiol 1976 ; 27 : 151-7
10. 10 Grigsby PW, Graham MV, Perez CA, Galakatos AE, Camel HM, Kao MS. Prospective phase I/II studies of definitive irradiation and chemotherapy for advanced gynecologic malignancies. Am J Clin Oncol 1996 ; 19 : 1-6
11. 11 Grigsby PW, Lu JD, Mutch DG, Kim RY, Eifel P. Twice daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: a phase II study of the Radiation Therapy Oncology Group 92-10. Int J Radiat Oncol Biol Phys 1998 ; 41 : 817-22
12. 12 Haie C, Pejovic MH, Gerbaulet A, Horiot JC, Pourquier H, Delouche J. Is prophylactic paraaortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotherapy group. Radiother Oncol 1988 ; 11 : 101-12
13. 13 Höckel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996 ; 56 : 4509-15
14. 14 Hreschchnyshyn MM, Aron BS, Boronow RC, Franklin E, Shingleton HM, Blessing JA. Hydroxyurea versus placebo combined with radiation to treat stages IIIB or IVA cervical cancer confined to the pelvis. Int J Radiat Oncol Biol Phys 1979 ; 5 : 317-26
15. 15 John M, Cooke K, Flam M, Padmanabhan A, Mowry PA. Premliminary results of concomitant radiotherapy and chemotherapy in advanced cervical cancer. Gynecol Oncol 1987 ; 28 : 101-5
16. 16 John M, Flam M, Markus M. A second generation phase II chemoradiation protocol for advanced cervical cancer. Proc Am Soc Clin Oncol 1991 ; 10: 190
17. 17 John M, Flam M, Sikic B, Rotman Cooper J, Malec M. Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma: a phase I-II prospective intergroup NCOG-RTOG study. Gynecol Oncol 1990 ; 37 : 1-5
18. 18 Kapp DS, Giaccia AJ. New directions for biology research in cancer of the uterine cervix. JNCI Monographs 1996 ; 21 :131-9
19. 19 Khoury GG, Bulman AS, Joslin CA, Rotwell RI. Concomitant pelvic irradiation, 5-fluorouracil and mitomycin C in the treatment of advanced cervical carcinoma. Br J Radiol 1991 ; 64 : 252-60
20. 20 Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P et al. Randomized study of radical surgery versus radiotherapy for stage I-II cervical cancer. Lancet 1997 ; 350 : 535-40
21. 21 Leborgne F, Leborgne JH, Doldan R, Zubizaretta E, Ortega B, Maisonneuve J et al. Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and a phase III randomized trial. Int J Radiat Oncol Biol phys 1997 ; 10 : 343-50
22. 22 Leibel S, Bauer M, Wasserman T, Marcial V, Rotman M, Hornback N et al. Radiotherapy with or without misonidazole for patients with stage IIIB or IVA of the uterine cervix. Int J Radiat Oncol Biol Phys 1987 ; 13 : 541-9
23. 23 Micheletti E, La Face B, Bianchi E et al. Continous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the uterine cervix IIB-IIIB (UICC). A phase I/II and pharmacokinetic study. Am J Clin Oncol 1997 ; 20 : 613-20
24. 24 Medical Research Council trial of misonidazole in carcinoma of the uterine cervix. A report from the MRC Working party on misonidazole for cancer of the cervix. Br J Radiol 1984 ; 57 : 491-9
25. 25 Muderspach LI, Curtin JP, Roman LD, Gebhardt JA, Klement V, Qian D et al. Carboplatin as a radiosensitizer in locally advanced cervical cancer: a pilot study. Gynecol Oncol 1997 ; 65 : 336-42
26. 26 Overgaard J, Bentzen SM, Kolstad P, Kjoerstad K, Davy M, Bertelsen K et al. Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1989 ; 16 : 1069-72
27. 27 Perez CA, Grigsby PW, Chao KSC, Mutch DG, Lockett MA. Tumor size, irradiation dose and long term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys 1998 ; 41 : 307-17
28. 28 Pras E, Willemse PH, Boonstra H, Hollema H, Heester MA, Szabo BG et al. Concurrent chemo-and radiotherapy in patients with locally advanced carcinoma of the cervix. Ann Oncol 1996 ; 7 : 511-6
29. 29 Rose B, Bundy B, Thigpen J. Preliminary results of a phase III randomized study of concomitant chemotherapy with weekly cisplatin versus hydroxyurea, 5-FU infusion and bolus cisplatin versus hydoxyurea in advanced cervical cancer: a GOG study [abstract]. Proceeding ASCO 1998
30. 30 Rotman M, Choi K, Guze C, Marcial V, Hornback N, John M. Prophylactic irradiation of the paraaortic lymph node chain in stage IIB and bulky stage I carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1990 ; 19 : 513-21
31. 31 Sinclair W. The combined effect of hydroxyurea and X-rays on Chinese hamster cells in vitro. Cancer Res 1968 ; 52 : 601-5
32. 32 Souhami L, Gil R, Allan SE, Canary VPC, Araujo CMMM, Pinto LH et al. A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix. J Clin Oncol 1991 ; 9 : 970-7
33. 33 Stehman FB, Bundy BN, Thomas G, Keys HM, d'Ablaing G, Fowler WC et al. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long term follow-up of a Gynecology Oncology Group. J Clin Oncol 1993 ; 11 : 1523-8
34. 34 Stehman FB, Bundy BN, Keys H, Currie JL, Mortel R, Creasman WT. A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix: a preliminary report of a Gynecology Oncology Group Study. Am J Obstet Gynecol 1988 ; 159 : 87-94
35. 35 Stehman FB, Bundy BN, Kucera PR, Deppe G, Reddy S, O'Connor DM. Hydroxyurea, 5-fluorouracil infusion and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecology Oncology group. Gynecol Oncol 1997 ; 66 : 262-7
36. 36 Tattersall, MHN, Ramirez C, Coppleson M. A randomized trial comparing platinum-based chemotherapy followed by radiotrherapy alone in patients with locally advanced cervical cancer. Int J Gynecol Oncol 1992 ; 2 : 224-51
37. 37 Thomas G, Dembo A, Ackerman I, Franssen E, Balogh J, Fyles A et al. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer. Gynecol Oncol 1998 ; 69 : 137-45
38. 38 Thomas G, Dembo A, Fyles F, Gadalla T, Beale F, Bean H et al. Concurrent chemoradiation in advanced cervical cancer. Gynecol Oncol 1990 ; 38 : 446-52
39. 39 Tseng CJ, Chang CT, Lai CH, Soong YK, Hong JH, Tang SG et al. A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecol Oncol 1997 ; 66 : 52-8
40. 40 Wong LC, Choo YC, Choy D, Sham JS, Ma HK. Long term follow-up of potentiation of radiotherapy by cisplatinum in advanced cervical cancer. Gynecol Oncol 1989 ; 35 : 159-63